HEADER TRANSFERASE/INHIBITOR 15-MAY-23 8SV9 TITLE CRYSTAL STRUCTURE OF ULK1 KINASE DOMAIN WITH INHIBITOR MR-2088 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE ULK1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AUTOPHAGY-RELATED PROTEIN 1 HOMOLOG,ATG1,HATG1,UNC-51-LIKE COMPND 6 KINASE 1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ULK1, KIAA0722; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS AUTOPHAGY, INHIBITOR, COMPLEX, KINASE, TRANSFERASE, TRANSFERASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.SCHONBRUNN,L.SUN REVDAT 1 27-MAR-24 8SV9 0 JRNL AUTH A.MOROZOVA,S.C.CHAN,S.BAYLE,L.SUN,D.GRASSIE,A.IERMOLAIEVA, JRNL AUTH 2 M.N.KALAGA,S.FRYDMAN,S.SANSIL,E.SCHONBRUNN,D.DUCKETT, JRNL AUTH 3 A.MONASTYRSKYI JRNL TITL DEVELOPMENT OF POTENT AND SELECTIVE ULK1/2 INHIBITORS BASED JRNL TITL 2 ON 7-AZAINDOLE SCAFFOLD WITH FAVORABLE IN VIVO PROPERTIES. JRNL REF EUR.J.MED.CHEM. V. 266 16101 2024 JRNL REFN ISSN 0223-5234 JRNL PMID 38232465 JRNL DOI 10.1016/J.EJMECH.2023.116101 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 29836 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1791 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.1800 - 5.4100 0.98 2342 150 0.1905 0.2147 REMARK 3 2 5.4000 - 4.2900 0.99 2237 143 0.1564 0.1914 REMARK 3 3 4.2900 - 3.7500 0.98 2221 142 0.1734 0.2076 REMARK 3 4 3.7500 - 3.4100 0.98 2200 140 0.2000 0.2287 REMARK 3 5 3.4100 - 3.1600 0.98 2183 139 0.2258 0.2464 REMARK 3 6 3.1600 - 2.9800 0.97 2155 138 0.2486 0.2931 REMARK 3 7 2.9800 - 2.8300 0.97 2172 138 0.2577 0.3074 REMARK 3 8 2.8300 - 2.7000 0.97 2134 137 0.2677 0.3381 REMARK 3 9 2.7000 - 2.6000 0.97 2142 136 0.2483 0.2959 REMARK 3 10 2.6000 - 2.5100 0.97 2135 137 0.2466 0.3387 REMARK 3 11 2.5100 - 2.4300 0.96 2100 134 0.2721 0.3315 REMARK 3 12 2.4300 - 2.3600 0.96 2090 133 0.2746 0.3109 REMARK 3 13 2.3600 - 2.3000 0.87 1934 124 0.2983 0.3276 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.450 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 NULL REMARK 3 ANGLE : 0.551 NULL REMARK 3 CHIRALITY : 0.041 675 REMARK 3 PLANARITY : 0.004 800 REMARK 3 DIHEDRAL : 10.558 651 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -29.9948 0.0012 19.9524 REMARK 3 T TENSOR REMARK 3 T11: 0.2776 T22: 0.2612 REMARK 3 T33: 0.2174 T12: -0.0410 REMARK 3 T13: -0.0062 T23: 0.0138 REMARK 3 L TENSOR REMARK 3 L11: 1.4844 L22: 0.5421 REMARK 3 L33: 0.9040 L12: -0.3936 REMARK 3 L13: -1.1399 L23: 0.2225 REMARK 3 S TENSOR REMARK 3 S11: -0.0057 S12: 0.0118 S13: 0.0703 REMARK 3 S21: -0.0451 S22: 0.0404 S23: 0.0058 REMARK 3 S31: 0.0279 S32: -0.0788 S33: -0.0318 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8SV9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1000274526. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-23 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : XSCALE VERSION JAN 10, 2022 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29836 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.20.1_4487 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M BIS-TRIS PH 5.5, 0.2 M REMARK 280 (NH4)2SO4, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 56.03000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 69.98000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 56.03000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 69.98000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 56.03000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 69.98000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 56.03000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 69.98000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A 303 LIES ON A SPECIAL POSITION. REMARK 375 S SO4 B 304 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 PRO A 3 REMARK 465 GLY A 4 REMARK 465 ARG A 5 REMARK 465 GLY A 6 REMARK 465 GLY A 7 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 PRO B 3 REMARK 465 GLY B 4 REMARK 465 ARG B 5 REMARK 465 GLY B 6 REMARK 465 GLY B 7 REMARK 465 PRO B 282 REMARK 465 SER B 283 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 19 CG CD CE NZ REMARK 470 ARG A 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 218 CG CD CE NZ REMARK 470 ARG B 152 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 153 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 237 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 20 40.35 -92.08 REMARK 500 ARG A 108 -51.80 65.39 REMARK 500 ASP A 138 45.81 -144.32 REMARK 500 ALA A 154 -165.09 -78.57 REMARK 500 PRO A 156 0.19 -64.93 REMARK 500 ASP A 165 80.98 60.93 REMARK 500 ASN B 52 74.57 -118.41 REMARK 500 ARG B 108 -62.74 61.60 REMARK 500 ASP B 138 50.14 -149.52 REMARK 500 ARG B 152 77.46 -69.32 REMARK 500 ASP B 165 77.34 61.46 REMARK 500 ALA B 179 7.57 -150.46 REMARK 500 ASP B 199 -151.91 -133.17 REMARK 500 LEU B 259 39.27 -96.26 REMARK 500 REMARK 500 REMARK: NULL DBREF 8SV9 A 1 283 UNP O75385 ULK1_HUMAN 1 283 DBREF 8SV9 B 1 283 UNP O75385 ULK1_HUMAN 1 283 SEQADV 8SV9 ALA A 37 UNP O75385 GLU 37 ENGINEERED MUTATION SEQADV 8SV9 ALA A 38 UNP O75385 LYS 38 ENGINEERED MUTATION SEQADV 8SV9 ALA B 37 UNP O75385 GLU 37 ENGINEERED MUTATION SEQADV 8SV9 ALA B 38 UNP O75385 LYS 38 ENGINEERED MUTATION SEQRES 1 A 283 MET GLU PRO GLY ARG GLY GLY THR GLU THR VAL GLY LYS SEQRES 2 A 283 PHE GLU PHE SER ARG LYS ASP LEU ILE GLY HIS GLY ALA SEQRES 3 A 283 PHE ALA VAL VAL PHE LYS GLY ARG HIS ARG ALA ALA HIS SEQRES 4 A 283 ASP LEU GLU VAL ALA VAL LYS CYS ILE ASN LYS LYS ASN SEQRES 5 A 283 LEU ALA LYS SER GLN THR LEU LEU GLY LYS GLU ILE LYS SEQRES 6 A 283 ILE LEU LYS GLU LEU LYS HIS GLU ASN ILE VAL ALA LEU SEQRES 7 A 283 TYR ASP PHE GLN GLU MET ALA ASN SEP VAL TYR LEU VAL SEQRES 8 A 283 MET GLU TYR CYS ASN GLY GLY ASP LEU ALA ASP TYR LEU SEQRES 9 A 283 HIS ALA MET ARG THR LEU SER GLU ASP THR ILE ARG LEU SEQRES 10 A 283 PHE LEU GLN GLN ILE ALA GLY ALA MET ARG LEU LEU HIS SEQRES 11 A 283 SER LYS GLY ILE ILE HIS ARG ASP LEU LYS PRO GLN ASN SEQRES 12 A 283 ILE LEU LEU SER ASN PRO ALA GLY ARG ARG ALA ASN PRO SEQRES 13 A 283 ASN SER ILE ARG VAL LYS ILE ALA ASP PHE GLY PHE ALA SEQRES 14 A 283 ARG TYR LEU GLN SER ASN MET MET ALA ALA TPO LEU CYS SEQRES 15 A 283 GLY SER PRO MET TYR MET ALA PRO GLU VAL ILE MET SER SEQRES 16 A 283 GLN HIS TYR ASP GLY LYS ALA ASP LEU TRP SER ILE GLY SEQRES 17 A 283 THR ILE VAL TYR GLN CYS LEU THR GLY LYS ALA PRO PHE SEQRES 18 A 283 GLN ALA SER SER PRO GLN ASP LEU ARG LEU PHE TYR GLU SEQRES 19 A 283 LYS ASN LYS THR LEU VAL PRO THR ILE PRO ARG GLU THR SEQRES 20 A 283 SER ALA PRO LEU ARG GLN LEU LEU LEU ALA LEU LEU GLN SEQRES 21 A 283 ARG ASN HIS LYS ASP ARG MET ASP PHE ASP GLU PHE PHE SEQRES 22 A 283 HIS HIS PRO PHE LEU ASP ALA SER PRO SER SEQRES 1 B 283 MET GLU PRO GLY ARG GLY GLY THR GLU THR VAL GLY LYS SEQRES 2 B 283 PHE GLU PHE SER ARG LYS ASP LEU ILE GLY HIS GLY ALA SEQRES 3 B 283 PHE ALA VAL VAL PHE LYS GLY ARG HIS ARG ALA ALA HIS SEQRES 4 B 283 ASP LEU GLU VAL ALA VAL LYS CYS ILE ASN LYS LYS ASN SEQRES 5 B 283 LEU ALA LYS SER GLN THR LEU LEU GLY LYS GLU ILE LYS SEQRES 6 B 283 ILE LEU LYS GLU LEU LYS HIS GLU ASN ILE VAL ALA LEU SEQRES 7 B 283 TYR ASP PHE GLN GLU MET ALA ASN SEP VAL TYR LEU VAL SEQRES 8 B 283 MET GLU TYR CYS ASN GLY GLY ASP LEU ALA ASP TYR LEU SEQRES 9 B 283 HIS ALA MET ARG THR LEU SER GLU ASP THR ILE ARG LEU SEQRES 10 B 283 PHE LEU GLN GLN ILE ALA GLY ALA MET ARG LEU LEU HIS SEQRES 11 B 283 SER LYS GLY ILE ILE HIS ARG ASP LEU LYS PRO GLN ASN SEQRES 12 B 283 ILE LEU LEU SER ASN PRO ALA GLY ARG ARG ALA ASN PRO SEQRES 13 B 283 ASN SER ILE ARG VAL LYS ILE ALA ASP PHE GLY PHE ALA SEQRES 14 B 283 ARG TYR LEU GLN SER ASN MET MET ALA ALA TPO LEU CYS SEQRES 15 B 283 GLY SER PRO MET TYR MET ALA PRO GLU VAL ILE MET SER SEQRES 16 B 283 GLN HIS TYR ASP GLY LYS ALA ASP LEU TRP SER ILE GLY SEQRES 17 B 283 THR ILE VAL TYR GLN CYS LEU THR GLY LYS ALA PRO PHE SEQRES 18 B 283 GLN ALA SER SER PRO GLN ASP LEU ARG LEU PHE TYR GLU SEQRES 19 B 283 LYS ASN LYS THR LEU VAL PRO THR ILE PRO ARG GLU THR SEQRES 20 B 283 SER ALA PRO LEU ARG GLN LEU LEU LEU ALA LEU LEU GLN SEQRES 21 B 283 ARG ASN HIS LYS ASP ARG MET ASP PHE ASP GLU PHE PHE SEQRES 22 B 283 HIS HIS PRO PHE LEU ASP ALA SER PRO SER MODRES 8SV9 SEP A 87 SER MODIFIED RESIDUE MODRES 8SV9 TPO A 180 THR MODIFIED RESIDUE MODRES 8SV9 SEP B 87 SER MODIFIED RESIDUE MODRES 8SV9 TPO B 180 THR MODIFIED RESIDUE HET SEP A 87 10 HET TPO A 180 11 HET SEP B 87 10 HET TPO B 180 11 HET WXH A 301 28 HET SO4 A 302 5 HET SO4 A 303 5 HET SO4 A 304 5 HET WXH B 301 28 HET SO4 B 302 5 HET SO4 B 303 5 HET SO4 B 304 5 HET EDO B 305 4 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM WXH (4P)-4-[(2P)-2-(1,2,5,6-TETRAHYDROPYRIDIN-3-YL)-1H- HETNAM 2 WXH PYRROLO[2,3-B]PYRIDIN-5-YL]-N-(2,2,2-TRIFLUOROETHYL) HETNAM 3 WXH THIOPHENE-2-CARBOXAMIDE HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 3 WXH 2(C19 H17 F3 N4 O S) FORMUL 4 SO4 6(O4 S 2-) FORMUL 11 EDO C2 H6 O2 FORMUL 12 HOH *128(H2 O) HELIX 1 AA1 ASN A 49 LYS A 51 5 3 HELIX 2 AA2 ASN A 52 LYS A 68 1 17 HELIX 3 AA3 ASP A 99 ARG A 108 1 10 HELIX 4 AA4 SER A 111 GLY A 133 1 23 HELIX 5 AA5 LYS A 140 GLN A 142 5 3 HELIX 6 AA6 SER A 184 MET A 188 5 5 HELIX 7 AA7 ALA A 189 MET A 194 1 6 HELIX 8 AA8 GLY A 200 GLY A 217 1 18 HELIX 9 AA9 SER A 225 ASN A 236 1 12 HELIX 10 AB1 SER A 248 LEU A 259 1 12 HELIX 11 AB2 ASP A 268 HIS A 274 1 7 HELIX 12 AB3 HIS A 275 ASP A 279 5 5 HELIX 13 AB4 ASN B 52 LYS B 68 1 17 HELIX 14 AB5 ASP B 99 ARG B 108 1 10 HELIX 15 AB6 SER B 111 GLY B 133 1 23 HELIX 16 AB7 LYS B 140 GLN B 142 5 3 HELIX 17 AB8 ASN B 155 ILE B 159 5 5 HELIX 18 AB9 SER B 184 MET B 188 5 5 HELIX 19 AC1 ALA B 189 MET B 194 1 6 HELIX 20 AC2 GLY B 200 GLY B 217 1 18 HELIX 21 AC3 SER B 225 ASN B 236 1 12 HELIX 22 AC4 SER B 248 LEU B 259 1 12 HELIX 23 AC5 ASP B 268 HIS B 274 1 7 HELIX 24 AC6 HIS B 275 ASP B 279 5 5 SHEET 1 AA1 6 GLU A 9 VAL A 11 0 SHEET 2 AA1 6 PHE A 14 HIS A 24 -1 O PHE A 16 N GLU A 9 SHEET 3 AA1 6 VAL A 29 HIS A 35 -1 O VAL A 30 N GLY A 23 SHEET 4 AA1 6 GLU A 42 CYS A 47 -1 O CYS A 47 N VAL A 29 SHEET 5 AA1 6 VAL A 88 GLU A 93 -1 O MET A 92 N ALA A 44 SHEET 6 AA1 6 LEU A 78 GLU A 83 -1 N ASP A 80 O VAL A 91 SHEET 1 AA2 2 ILE A 134 ILE A 135 0 SHEET 2 AA2 2 ARG A 170 TYR A 171 -1 O ARG A 170 N ILE A 135 SHEET 1 AA3 2 ILE A 144 SER A 147 0 SHEET 2 AA3 2 ARG A 160 ILE A 163 -1 O ARG A 160 N SER A 147 SHEET 1 AA4 6 GLU B 9 VAL B 11 0 SHEET 2 AA4 6 PHE B 14 GLY B 25 -1 O PHE B 16 N GLU B 9 SHEET 3 AA4 6 ALA B 28 HIS B 35 -1 O VAL B 30 N GLY B 23 SHEET 4 AA4 6 GLU B 42 CYS B 47 -1 O CYS B 47 N VAL B 29 SHEET 5 AA4 6 VAL B 88 GLU B 93 -1 O LEU B 90 N LYS B 46 SHEET 6 AA4 6 LEU B 78 GLU B 83 -1 N ASP B 80 O VAL B 91 SHEET 1 AA5 2 ILE B 134 ILE B 135 0 SHEET 2 AA5 2 ARG B 170 TYR B 171 -1 O ARG B 170 N ILE B 135 SHEET 1 AA6 2 ILE B 144 SER B 147 0 SHEET 2 AA6 2 ARG B 160 ILE B 163 -1 O LYS B 162 N LEU B 145 LINK C ASN A 86 N SEP A 87 1555 1555 1.33 LINK C SEP A 87 N VAL A 88 1555 1555 1.33 LINK C ALA A 179 N TPO A 180 1555 1555 1.33 LINK C TPO A 180 N LEU A 181 1555 1555 1.33 LINK C ASN B 86 N SEP B 87 1555 1555 1.33 LINK C SEP B 87 N VAL B 88 1555 1555 1.33 LINK C ALA B 179 N TPO B 180 1555 1555 1.33 LINK C TPO B 180 N LEU B 181 1555 1555 1.33 CRYST1 112.060 139.960 87.450 90.00 90.00 90.00 C 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008924 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007145 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011435 0.00000